Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Prince

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|October 6, 2000
Docetaxel effectively mobilizes peripheral blood CD34+ cellsH M Prince, G C Toner, J F Seymour, et al.
Bone Marrow Transplantation|November 17, 2009
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantationP J Shaughnessy, B J Bolwell, K van Besien, et al.
Rheumatology (Oxford, England)|February 1, 2011
An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children registerFemke H M Prince, Esther W de Bekker-Grob, Marinka Twilt, et al.
Rheumatology (Oxford, England)|July 18, 2008
Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nlF H M Prince, I S Ferket, S Kamphuis, et al.
Internal Medicine Journal|January 14, 2015
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Gene Therapy|March 5, 2010
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigenS Peinert, H M Prince, P M Guru, et al.
The Journal of Rheumatology|January 19, 2010
Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanerceptMarieke H Otten, Femke H M Prince, Marinka Twilt, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Annals of the Rheumatic Diseases|June 16, 2009
When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritisF H M Prince, M Twilt, S C M Simon, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|October 6, 2000
Docetaxel effectively mobilizes peripheral blood CD34+ cellsH M Prince, G C Toner, J F Seymour, et al.
Bone Marrow Transplantation|November 17, 2009
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantationP J Shaughnessy, B J Bolwell, K van Besien, et al.
Rheumatology (Oxford, England)|February 1, 2011
An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children registerFemke H M Prince, Esther W de Bekker-Grob, Marinka Twilt, et al.
Rheumatology (Oxford, England)|July 18, 2008
Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nlF H M Prince, I S Ferket, S Kamphuis, et al.
Internal Medicine Journal|January 14, 2015
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Gene Therapy|March 5, 2010
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigenS Peinert, H M Prince, P M Guru, et al.
The Journal of Rheumatology|January 19, 2010
Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanerceptMarieke H Otten, Femke H M Prince, Marinka Twilt, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Annals of the Rheumatic Diseases|June 16, 2009
When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritisF H M Prince, M Twilt, S C M Simon, et al.
Pageof 16